BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2731449)

  • 1. Aztreonam in the treatment of bacterial meningitis.
    Ayroza-Galvão PA; Milstein-Kuschnaroff TM; Mimica IM; Maassen S; Barbosa Júnior SP; Cavalcante NJ; Lorenco R; Mimica LM; Martino MD
    Chemotherapy; 1989; 35 Suppl 1():39-44. PubMed ID: 2731449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.
    Feris J; Moledina N; Rodriguez WJ; Khan WN; Puig J; Wiedermann BL; Ahmad S
    Chemotherapy; 1989; 35 Suppl 1():31-8. PubMed ID: 2731448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aztreonam in the treatment of gram-negative bacterial meningitis.
    Lentnek AL; Williams RR
    Rev Infect Dis; 1991; 13 Suppl 7():S586-90. PubMed ID: 2068463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation on aztreonam in pediatric field and fundamental study on its penetration into cerebrospinal fluid].
    Okada T; Furukawa S
    Jpn J Antibiot; 1985 Nov; 38(11):3323-33. PubMed ID: 4094065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacteriological, pharmacokinetic and clinical studies on aztreonam in the pediatric field. Pediatric Study Group of Aztreonam].
    Fuyii R; Meguro H; Arimasu O; Sunakawa K; Ishizuka Y; Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H
    Jpn J Antibiot; 1985 Nov; 38(11):3195-216. PubMed ID: 3912524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aztreonam in the treatment of gram-negative meningitis in children.
    Isani Z; Rehman N; Adil N; el Messidi M
    Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of aztreonam against pediatric purulent meningitis].
    Fujii R; Meguro H; Nishimura T; Kobayashi Y; Haruta T; Toyonaga Y; Okada T; Furukawa S; Kitamura I; Ogura H
    Jpn J Antibiot; 1988 Apr; 41(4):390-8. PubMed ID: 3136257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefuroxime treatment of bacterial meningitis in infants and children.
    Sirinavin S; Chiemchanya S; Visudhipan P; Lolekha S
    Antimicrob Agents Chemother; 1984 Feb; 25(2):273-5. PubMed ID: 6608921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fundamental and clinical studies on aztreonam in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1985 Nov; 38(11):3273-84. PubMed ID: 4094059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aztreonam for treating meningitis caused by gram-negative rods.
    Kilpatrick M; Girgis N; Farid Z; Bishay E
    Scand J Infect Dis; 1991; 23(1):125-6. PubMed ID: 2028226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
    Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
    Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fundamental and clinical studies of aztreonam in the field of pediatric].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H; Nakazawa S; Chikaoka H; Kamigaki M; Koido R; Nakada Y
    Jpn J Antibiot; 1985 Nov; 38(11):3239-62. PubMed ID: 4094057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis.
    Scheld WM; Brodeur JP; Foresman PA; Gratz JC; Rodeheaver GT
    Rev Infect Dis; 1985; 7 Suppl 4():S635-47. PubMed ID: 3909319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aztreonam therapy for serious gram-negative infections in children.
    Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
    Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral aztreonam in the treatment of Haemophilus influenzae type b meningitis in Egyptian children.
    Girgis NI; Abu el Ella AH; Farid Z; Woody JN; Haberberger RL; el Messidy M; Dessouky A
    Scand J Infect Dis; 1988; 20(1):111-2. PubMed ID: 3259009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with aztreonam for treatment of infections in children.
    Stutman HR
    Rev Infect Dis; 1991; 13 Suppl 7():S582-5. PubMed ID: 2068462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy of aztreonam in refractory infections in children].
    Ogura H; Hamada F; Fujieda M; Matsumoto K; Araki K; Ogura Y; Kuramitsu M; Kurashige T; Kitamura I
    Jpn J Antibiot; 1985 Nov; 38(11):3349-57. PubMed ID: 4094068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of cefotaxime in gram-negative meningitis.
    LeFrock JL; Molavi A; Smith B; Black P; Rosenberg M; Rolston K; Brodner R; Chandrasekar P; Henao L; Kannangara DW
    Neurosurgery; 1984 Nov; 15(5):679-82. PubMed ID: 6095133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.